This product was recently added by customer request, and is available for your convenience More relevant content may be added as customer demand increases Rozanolixizumab works by blocking a protein called the neonatal fc receptor (fcrn) This protein helps harmful igg antibodies survive in people with generalized myasthenia gravis (gmg) By reducing these antibody levels, the drug can improve muscle strength in people with gmg.
WATCH
